Ibandronate Sodium Tablet, Film Coated
Product Images NDC 33342-150

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ibandronate Sodium (NDC 33342-150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Macleods Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Ibandronate Box

FDA Label Image

Ibandronate Monocarton

Ibandronate Monocarton
This appears to be a label for a medication called "Ibandronate" manufactured by Macleods Pharma USA, Inc. The medication is in the form of a once-monthly tablet and comes in 150 mg strength. The label includes dosage instructions and storage guidelines. There is also a NDC (National Drug Code) number provided.*
FDA Label Image

Structure (Ibandronate Structure)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.